Follow
Adam M. Farkas Ph.D.
Adam M. Farkas Ph.D.
Icahn School of Medicine at Mount Sinai
Verified email at pitt.edu
Title
Cited by
Cited by
Year
Integrated genomic characterization of endometrial carcinoma
DA Levine, ...
Nature 497 (7447), 67-73, 2013
51242013
Endogenous HMGB1 regulates autophagy
D Tang, R Kang, KM Livesey, CW Cheh, A Farkas, P Loughran, G Hoppe, ...
Journal of Cell Biology 190 (5), 881-892, 2010
10742010
Induction of Th17 cells by segmented filamentous bacteria in the murine intestine
AM Farkas, C Panea, Y Goto, G Nakato, M Galan-Diez, S Narushima, ...
Journal of Immunological Methods 421, 104-111, 2015
657*2015
The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival
R Kang, D Tang, NE Schapiro, KM Livesey, A Farkas, P Loughran, ...
Cell Death & Differentiation 17 (4), 666-676, 2010
3932010
Intestinal Monocyte-Derived Macrophages Control Commensal-Specific Th17 Responses
C Panea, AM Farkas, Y Goto, S Abdollahi-Roodsaz, C Lee, B Koscso, ...
Cell Reports 12, 1-11, 2015
1552015
Estrogen receptor β functions through nongenomic mechanisms in lung cancer cells
GF Zhang, X Liu, AM Farkas, AV Parwani, KL Lathrop, D Lenzner, ...
Molecular endocrinology 23 (2), 146-156, 2009
1422009
Fibroblast growth factor receptor 3 alterations and response to PD-1/PD-L1 blockade in patients with metastatic urothelial cancer
L Wang, Y Gong, A Saci, PM Szabo, A Martini, A Necchi, A Siefker-Radtke, ...
European urology 76 (5), 599-603, 2019
1182019
TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer
MD Park, I Reyes-Torres, J LeBerichel, P Hamon, NM LaMarche, ...
Nature immunology 24 (5), 792-801, 2023
782023
NKG2A and HLA-E define an alternative immune checkpoint axis in bladder cancer
B Salomé, JP Sfakianos, D Ranti, J Daza, C Bieber, A Charap, C Hammer, ...
Cancer Cell 40 (9), 1027-1043. e9, 2022
742022
Myeloid cell–associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing
L Wang, JP Sfakianos, KG Beaumont, G Akturk, A Horowitz, RP Sebra, ...
Clinical Cancer Research 27 (15), 4287-4300, 2021
622021
Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration
S Cascio, AM Farkas, RP Hughey, OJ Finn
Oncotarget 4 (10), 1686, 2013
532013
Bacillus Calmette-Guerin (BCG): Its fight against pathogens and cancer
JP Sfakianos, B Salome, J Daza, A Farkas, N Bhardwaj, A Horowitz
Urologic Oncology: Seminars and Original Investigations 39 (2), 121-129, 2021
452021
Vaccines based on abnormal self-antigens as tumor-associated antigens: immune regulation
AM Farkas, OJ Finn
Seminars in immunology 22 (3), 125-131, 2010
382010
Editorial overview Detecting DNA: Getting and begetting cancer
AM Farkas, TM Kilgore, MT Lotze
Current Opinion in Investigational Drugs 8 (12), 2007
362007
Biological activities of cytokine‐neutralizing hyaluronic acid–antibody conjugates
LT Sun, SA Bencherif, TW Gilbert, AM Farkas, MT Lotze, NR Washburn
Wound repair and regeneration 18 (3), 302-310, 2010
242010
Immune phenotype of peripheral blood mononuclear cells in patients with high-risk non-muscle invasive bladder cancer
F Audenet, AM Farkas, H Anastos, MD Galsky, N Bhardwaj, JP Sfakianos
World journal of urology 36, 1741-1748, 2018
212018
Tim-3 and TIGIT mark Natural Killer cells susceptible to effector dysfunction in human bladder cancer
AM Farkas, F Audenet, H Anastos, M Galsky, J Sfakianos, N Bhardwaj
The Journal of Immunology 200 (1_Supplement), 124.14-124.14, 2018
152018
TIM-3 and TIGIT are possible immune checkpoint targets in patients with bladder cancer
K Attalla, AM Farkas, H Anastos, F Audenet, MD Galsky, N Bhardwaj, ...
Urologic Oncology: Seminars and Original Investigations 40 (9), 403-406, 2022
132022
Harnessing natural killer cell function for genitourinary cancers
N Bhardwaj, AM Farkas, Z Gul, JP Sfakianos
Urologic Clinics of North America 47 (4), 433-442, 2020
102020
Antigen choice determines vaccine-induced generation of immunogenic versus tolerogenic dendritic cells that are marked by differential expression of pancreatic enzymes
AM Farkas, DM Marvel, OJ Finn
The Journal of Immunology 190 (7), 3319-3327, 2013
102013
The system can't perform the operation now. Try again later.
Articles 1–20